CJ-30061

· HK inno.N Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CJ-30061, covering 2018-08-21 to 2018-08-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia [Phase 3]